MOTTOLA FRANK (Sr VP, Quality, GMP Oper. & IT) sold 8.1% of their position (1.62K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $87.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/10/2026ACC: 0001804567-26-000010
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
-3.42K
Net shares
Net seller
$185.2K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
3.75K acquired · 7.17K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
20.7%
3/6/2026
18.11K→21.86K
Common Stock
Direct
Shares
−1.79K
Price / share
$54.73
Trade value
$98.13K
% of position
8.2%
3/6/2026
21.86K→20.06K
Common Stock
Direct
Shares
−1.62K
Price / share
$53.65
Trade value
$87.07K
% of position
8.1%
3/9/2026
20.06K→18.44K
Total
Net shares
+334.00
Net value
-$185.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | M · Option Exercise | +3.75K | — | — | 20.7% | 18.11K | 21.86K |
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −1.79K | $54.73 | $98.13K | 8.2% | 21.86K | 20.06K |
| Common Stock Direct | 3/9/2026 | S · Sale | −1.62K | $53.65 | $87.07K | 8.1% | 20.06K | 18.44K |
| Total | +334.00 | -$185.20K | ||||||
Derivative Transactions1
Performance Share Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
0
Held after
0.00
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Share Unit Direct | Common Stock3.75K shares | 3/6/2026 | M · Option Exercise | −3.75K | 0 | — | 0.00 |